Caldwell Trust’s Integra LifeSciences IART Stock Holding History

Caldwell Trust’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.88K	Hold	200	–	–	﹤0.01%	759
2025 Q4	$2.48K	Hold	200	–	–	﹤0.01%	723
2025 Q3	$2.87K	Hold	200	–	–	﹤0.01%	712
2025 Q2	$2.45K	Hold	200	–	–	﹤0.01%	715
2025 Q1	$4.4K	Hold	200	–	–	﹤0.01%	696
2024 Q4	$4.54K	Hold	200	–	–	﹤0.01%	661
2024 Q3	$3.63K	Hold	200	–	–	﹤0.01%	663
2024 Q2	$5.83K	Hold	200	–	–	﹤0.01%	645
2024 Q1	$7.09K	Hold	200	–	–	﹤0.01%	641
2023 Q4	$8.71K	Hold	200	–	–	﹤0.01%	618
2023 Q3	$7.64K	Hold	200	–	–	﹤0.01%	628
2023 Q2	$8.23K	Hold	200	–	–	﹤0.01%	640
2023 Q1	$11.5K	Hold	200	–	–	﹤0.01%	612
2022 Q4	$11.2K	Hold	200	–	–	﹤0.01%	605
2022 Q3	$8.47K	Hold	200	–	–	﹤0.01%	625
2022 Q2	$10.8K	Hold	200	–	–	﹤0.01%	621
2022 Q1	$12.9K	Hold	200	–	–	﹤0.01%	620
2021 Q4	$13.4K	Hold	200	–	–	﹤0.01%	609
2021 Q3	$13.7K	Hold	200	–	–	﹤0.01%	600
2021 Q2	$13.6K	Buy	200 +100	+100%	+$7.07K	﹤0.01%	613
2021 Q1	$6.91K	Buy	+100	New	+$6.78K	﹤0.01%	652
2020 Q1	–	Sell	-100	Closed	-$5.83K	–	813
2019 Q4	$5.83K	Buy	+100	New	+$5.95K	﹤0.01%	729

Other funds holding IART

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Caldwell Trust's IART Position: Q1 2026 in Review

Caldwell Trust held its Integra LifeSciences (IART) position steady in Q1 2026 at 200 shares worth $1.88K. The position accounts for ﹤0.01% of the portfolio, ranked #759.

Caldwell Trust first reported a position in IART in Q4 2019 and has held it in 22 quarters since. The position peaked at $13.7K in Q3 2021. 201 funds tracked by Wall St. Rank hold IART as of Q1 2026.

Caldwell Trust held 200 shares of Integra LifeSciences worth $1.88K as of Q1 2026.
Caldwell Trust left its Integra LifeSciences share count unchanged in Q1 2026.
Integra LifeSciences made up ﹤0.01% of Caldwell Trust's portfolio in Q1 2026, its #759 holding.
Caldwell Trust first reported a position in Integra LifeSciences in Q4 2019 and has held it in 22 quarters since.
Caldwell Trust's Integra LifeSciences position peaked at $13.7K in Q3 2021.
201 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2026.

Based on Caldwell Trust's 13F filing for Q1 2026, filed 22 Apr 2026.